These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26449630)

  • 1. Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis.
    Marinovich ML; Macaskill P; Irwig L; Sardanelli F; Mamounas E; von Minckwitz G; Guarneri V; Partridge SC; Wright FC; Choi JH; Bhattacharyya M; Martincich L; Yeh E; Londero V; Houssami N
    BMC Cancer; 2015 Oct; 15():662. PubMed ID: 26449630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy.
    Marinovich ML; Macaskill P; Irwig L; Sardanelli F; von Minckwitz G; Mamounas E; Brennan M; Ciatto S; Houssami N
    Br J Cancer; 2013 Sep; 109(6):1528-36. PubMed ID: 23963140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Chagpar AB; Middleton LP; Sahin AA; Dempsey P; Buzdar AU; Mirza AN; Ames FC; Babiera GV; Feig BW; Hunt KK; Kuerer HM; Meric-Bernstam F; Ross MI; Singletary SE
    Ann Surg; 2006 Feb; 243(2):257-64. PubMed ID: 16432360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.
    Marinovich ML; Sardanelli F; Ciatto S; Mamounas E; Brennan M; Macaskill P; Irwig L; von Minckwitz G; Houssami N
    Breast; 2012 Oct; 21(5):669-77. PubMed ID: 22863284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
    Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
    Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
    Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
    AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy.
    Park J; Chae EY; Cha JH; Shin HJ; Choi WJ; Choi YW; Kim HH
    Eur J Radiol; 2018 Nov; 108():261-268. PubMed ID: 30396666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
    Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
    Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
    McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
    Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
    Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
    J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.
    Lee MC; Gonzalez SJ; Lin H; Zhao X; Kiluk JV; Laronga C; Mooney B
    Ann Surg Oncol; 2015 Sep; 22(9):2888-94. PubMed ID: 25589151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.
    Guarneri V; Pecchi A; Piacentini F; Barbieri E; Dieci MV; Ficarra G; Tazzioli G; Frassoldati A; Battista R; Canossi B; Mauri C; D'Amico R; Conte P; Torricelli P
    Ann Surg Oncol; 2011 Aug; 18(8):2150-7. PubMed ID: 21301969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.
    Keune JD; Jeffe DB; Schootman M; Hoffman A; Gillanders WE; Aft RL
    Am J Surg; 2010 Apr; 199(4):477-84. PubMed ID: 20359567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
    Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
    An YY; Kim SH; Kang BJ
    World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer.
    Wasif N; Garreau J; Terando A; Kirsch D; Mund DF; Giuliano AE
    Am Surg; 2009 Oct; 75(10):970-5. PubMed ID: 19886147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative accuracy of preoperative tumor size assessment on mammography, sonography, and MRI: Is the accuracy affected by breast density or cancer subtype?
    Leddy R; Irshad A; Metcalfe A; Mabalam P; Abid A; Ackerman S; Lewis M
    J Clin Ultrasound; 2016 Jan; 44(1):17-25. PubMed ID: 26294391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.
    Kim YS; Chang JM; Moon HG; Lee J; Shin SU; Moon WK
    Ann Surg Oncol; 2016 Apr; 23(4):1135-42. PubMed ID: 26628432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3.0 T magnetic resonance imaging and X-ray mammography in the measurement of ductal carcinoma in situ: a comparison with histopathology.
    Pickles MD; Gibbs P; Hubbard A; Rahman A; Wieczorek J; Turnbull LW
    Eur J Radiol; 2015 Apr; 84(4):603-10. PubMed ID: 25604907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.